The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel

BACKGROUND: Paclitaxel plays a central role in chemotherapy for breast cancer. Peripheral neuropathy, a well-known toxicity with paclitaxel, may be of interest in predicting the efficacy of paclitaxel therapy for patients with metastatic breast cancer. We performed a retrospective analysis assessing...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukada, Ippei, Ito, Yoshinori, Kobayashi, Kokoro, Shibayama, Tomoko, Takahashi, Shunji, Horii, Rie, Akiyama, Futoshi, Iwase, Takuji, Ohno, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595337/
https://www.ncbi.nlm.nih.gov/pubmed/28898275
http://dx.doi.org/10.1371/journal.pone.0184322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595337/
https://www.ncbi.nlm.nih.gov/pubmed/28898275
http://dx.doi.org/10.1371/journal.pone.0184322

Ejemplares similares